10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2010 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2010 10-K (Filed: Feb 18, 2011) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | |
| Cash flows from operating activities: | |||
| Cash receipts from revenues | $ 94,503 | 93,568 | 82,250 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (73,143) | (73,536) | (64,131) |
| Cash paid to other suppliers and employees | (13,778) | (13,121) | (11,832) |
| Interest and dividends received | 4 | 5 | 20 |
| Interest paid | (583) | (542) | (574) |
| Income taxes paid | (2,224) | (2,339) | (1,786) |
| Net cash provided by operating activities | 4,779 | 4,035 | 3,947 |
| Cash flows from investing activities: | |||
| Additions to property and equipment | (2,005) | (2,548) | (2,180) |
| Proceeds from sale-leaseback transactions | 507 | 1,562 | 204 |
| Acquisitions (net of cash acquired) and other investments | (177) | (101) | (2,651) |
| Purchase of short-term investments | (5) | ||
| Proceeds from sale or maturity of short-term investments | 1 | 28 | |
| Proceeds from sale or disposal of assets | 34 | 23 | 19 |
| Net cash used in investing activities | (1,640) | (1,069) | (4,580) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (15) | (2,729) | 959 |
| Repayment of debt assumed in acquisition | (353) | ||
| Issuance of long-term debt | 991 | 2,800 | 350 |
| Repayments of long-term debt | (2,103) | (653) | (2) |
| Dividends paid | (479) | (439) | (383) |
| Derivative settlements | (5) | (3) | |
| Proceeds from exercise of stock options | 285 | 250 | 328 |
| Excess tax benefits from stock-based compensation | 28 | 19 | 53 |
| Repurchase of common stock | (1,500) | (2,477) | (23) |
| Net cash provided by (used in) financing activities | (2,798) | (3,232) | 929 |
| Net increase (decrease) in cash and cash equivalents | 341 | (266) | 296 |
| Cash and cash equivalents at beginning of year | 1,086 | 1,352 | |
| Cash and cash equivalents at end of year | 1,427 | 1,086 | 1,352 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 3,424 | 3,696 | 3,212 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,469 | 1,389 | 1,274 |
| Stock-based compensation | 150 | 165 | 92 |
| Deferred income taxes and other noncash items | 30 | 48 | (3) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | 532 | (86) | (291) |
| Inventories | (352) | (1,199) | (488) |
| Other current assets | (4) | 48 | 12 |
| Other assets | (210) | (2) | 19 |
| Accounts payable | (40) | 4 | (64) |
| Accrued expenses | (176) | (66) | 183 |
| Other long-term liabilities | (44) | 38 | 1 |
| Net cash provided by operating activities | 4,779 | 4,035 | 3,947 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |